{"id":14143,"date":"2023-05-08T11:08:03","date_gmt":"2023-05-08T09:08:03","guid":{"rendered":"https:\/\/udic.es\/?p=14143"},"modified":"2024-02-14T19:35:56","modified_gmt":"2024-02-14T18:35:56","slug":"resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua","status":"publish","type":"post","link":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/","title":{"rendered":"Resultat positiu de l&#8217;assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua"},"content":{"rendered":"<p>Resultats altament positius de l&#8217;assaig pivotal de fase III BouNDless que avalua ND0612 en pacients amb malaltia de Parkinson amb fluctuacions motores.<br \/>\nNeuroDerm, subsidi\u00e0ria de Mitsubishi Tanabe Pharma va anunciar els resultats positius el gener 2023 d&#8217;aquesta infusi\u00f3 subcut\u00e0nia 24h\/d de levodopa\/carbidopa, amb una marcada millora del temps ON sense disc\u00ednsies molestes i una reducci\u00f3 del temps OFF<br \/>\nAquesta informaci\u00f3 s&#8217;ha enviat a les autoritats reguladores dels EUA i de la Uni\u00f3 Europea.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Resultats altament positius de l&#8217;assaig pivotal de fase III BouNDless que avalua ND0612 en pacients amb malaltia de Parkinson amb fluctuacions motores. NeuroDerm, subsidi\u00e0ria de Mitsubishi Tanabe Pharma va anunciar els resultats positius el gener 2023 d&#8217;aquesta infusi\u00f3 subcut\u00e0nia 24h\/d de levodopa\/carbidopa, amb una marcada millora del temps ON sense disc\u00ednsies molestes i una reducci\u00f3&#8230;<\/p>\n","protected":false},"author":5,"featured_media":9250,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[125],"tags":[],"class_list":["post-14143","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-parkinson-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Resultat positiu de l&#039;assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"description\" content=\"Resultats altament positius de l&#039;assaig pivotal de fase III BouNDless que avalua ND0612 en pacients amb malaltia de Parkinson amb fluctuacions motores.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Resultat positiu de l&#039;assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:description\" content=\"Resultats altament positius de l&#039;assaig pivotal de fase III BouNDless que avalua ND0612 en pacients amb malaltia de Parkinson amb fluctuacions motores.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-08T09:08:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-14T18:35:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"815\" \/>\n\t<meta property=\"og:image:height\" content=\"246\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Anais\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anais\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/\"},\"author\":{\"name\":\"Anais\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/47c147b5836dcc61f2cde77c55acd6e8\"},\"headline\":\"Resultat positiu de l&#8217;assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua\",\"datePublished\":\"2023-05-08T09:08:03+00:00\",\"dateModified\":\"2024-02-14T18:35:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/\"},\"wordCount\":92,\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"articleSection\":[\"Parkinson\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/\",\"url\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/\",\"name\":\"Resultat positiu de l'assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"datePublished\":\"2023-05-08T09:08:03+00:00\",\"dateModified\":\"2024-02-14T18:35:56+00:00\",\"description\":\"Resultats altament positius de l'assaig pivotal de fase III BouNDless que avalua ND0612 en pacients amb malaltia de Parkinson amb fluctuacions motores.\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#primaryimage\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"width\":815,\"height\":246,\"caption\":\"logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Resultat positiu de l&#8217;assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/47c147b5836dcc61f2cde77c55acd6e8\",\"name\":\"Anais\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7ed5cf308b81b1b2a9a240a98a4dff6d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7ed5cf308b81b1b2a9a240a98a4dff6d?s=96&d=mm&r=g\",\"caption\":\"Anais\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Resultat positiu de l'assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"Resultats altament positius de l'assaig pivotal de fase III BouNDless que avalua ND0612 en pacients amb malaltia de Parkinson amb fluctuacions motores.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/","og_locale":"ca_ES","og_type":"article","og_title":"Resultat positiu de l'assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","og_description":"Resultats altament positius de l'assaig pivotal de fase III BouNDless que avalua ND0612 en pacients amb malaltia de Parkinson amb fluctuacions motores.","og_url":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/","og_site_name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_published_time":"2023-05-08T09:08:03+00:00","article_modified_time":"2024-02-14T18:35:56+00:00","og_image":[{"width":815,"height":246,"url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","type":"image\/png"}],"author":"Anais","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Anais","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#article","isPartOf":{"@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/"},"author":{"name":"Anais","@id":"https:\/\/udic.es\/#\/schema\/person\/47c147b5836dcc61f2cde77c55acd6e8"},"headline":"Resultat positiu de l&#8217;assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua","datePublished":"2023-05-08T09:08:03+00:00","dateModified":"2024-02-14T18:35:56+00:00","mainEntityOfPage":{"@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/"},"wordCount":92,"publisher":{"@id":"https:\/\/udic.es\/#organization"},"image":{"@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","articleSection":["Parkinson"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/","url":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/","name":"Resultat positiu de l'assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#primaryimage"},"image":{"@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","datePublished":"2023-05-08T09:08:03+00:00","dateModified":"2024-02-14T18:35:56+00:00","description":"Resultats altament positius de l'assaig pivotal de fase III BouNDless que avalua ND0612 en pacients amb malaltia de Parkinson amb fluctuacions motores.","breadcrumb":{"@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#primaryimage","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","width":815,"height":246,"caption":"logo"},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/ca\/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/ca\/"},{"@type":"ListItem","position":2,"name":"Resultat positiu de l&#8217;assaig Pivotal amb levodopa administrada mitjan\u00e7ant infusi\u00f3 subcut\u00e0nia cont\u00ednua"}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]},{"@type":"Person","@id":"https:\/\/udic.es\/#\/schema\/person\/47c147b5836dcc61f2cde77c55acd6e8","name":"Anais","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7ed5cf308b81b1b2a9a240a98a4dff6d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7ed5cf308b81b1b2a9a240a98a4dff6d?s=96&d=mm&r=g","caption":"Anais"}}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts\/14143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/comments?post=14143"}],"version-history":[{"count":0,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts\/14143\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/media\/9250"}],"wp:attachment":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/media?parent=14143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/categories?post=14143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/tags?post=14143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}